Sanger Sequencing | Hematologics

STAT3 Mutation Analysis

Sanger sequencing of STAT3 exons 19, 20, and 21 mutations for T-LGL leukemia diagnosis. Cell sorting available for increased sensitivity.

STAT3 Mutation AnalysisEric Johnson2026-05-03T16:04:05-07:00

Sanger sequencing of CXCR4 c-terminal mutations associated with ibrutinib resistance in Waldenström's macroglobulinemia.

CXCR4 Mutation AnalysisEric Johnson2026-05-03T16:03:03-07:00

Sanger sequencing of IDH1 exon 4 mutations including R132 to inform IDH inhibitor treatment decisions.

IDH1 Mutation AnalysisEric Johnson2026-05-03T16:03:03-07:00

Sanger sequencing of IDH2 exon 4 mutations at codons R140 and R172 to inform IDH inhibitor treatment decisions.

IDH2 Mutation AnalysisEric Johnson2026-05-03T16:03:03-07:00

Sanger sequencing of ABL1 tyrosine kinase domain to detect imatinib resistance mutations in BCR::ABL1-positive CML, ALL, and AML.

ABL1 Tyrosine Kinase Domain Mutation AnalysisEric Johnson2026-05-03T16:03:03-07:00

Sanger sequencing detection of the BRAF V600E mutation for hairy cell leukemia diagnosis and monitoring.

BRAF V600E Mutation AnalysisEric Johnson2026-05-03T16:03:03-07:00